Document:

Exhibit 4.1

      

      

      WARRANT AGREEMENT

      

      

      LDH GROWTH CORP I

      

      

      and

      

      

      CONTINENTAL STOCK TRANSFER & TRUST COMPANY

      

      

      Dated March 18, 2021

      

      

      THIS WARRANT AGREEMENT (this “Agreement”), dated March 18, 2021, is by and between LDH Growth Corp I, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant
          Agent”).

      

      

      WHEREAS, it is proposed that the Company enter into that certain Private Placement Warrants Purchase Agreement, with LDH Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor will purchase an aggregate of 4,866,667 warrants (or up to 5,266,667 warrants if the underwriters in the Offering (defined below) exercise their Over-allotment Option (as
        defined below) in full) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable), bearing the legend set forth in Exhibit B hereto (the “Private
          Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant.  Each Private Placement Warrant entitles the holder thereof to purchase one Ordinary Share (as defined below) at a price of $11.50 per share, subject to
        adjustment as described herein;

      

      

      WHEREAS, in connection with the consummation of the Offering (as defined below), the Company will enter into certain Forward Purchase Agreement with LDH Sponsor LLC (the “Forward Purchase Investor”) pursuant to which the Forward Purchase Investor will purchase units (the “Forward Purchase Units”) for up to an aggregate purchase price of
        $50,000,000 with each Forward Purchase Unit having a purchase price of $10.00 and consisting of one share of the Class A ordinary share (the “Forward Purchase Shares”), and one-fifth of
        one warrant bearing the legend set forth in Exhibit B hereto (the “Forward Purchase Warrants” and together with the shares of Class A ordinary shares issuable upon the exercise thereof,
        the Forward Purchase Units and the Forward Purchase Shares, the “Forward Purchase Securities”) in one or more private placement transactions to occur in such amounts and at such time or
        times as the Forward Purchase Investor determines, but no later than simultaneously with the closing of the Company’s initial Business Combination;

      

      

      WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving
        the Company and one or more businesses (a “Business Combination”), the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated
        to, loan the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 1,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant; and

      

      

      WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one
        Ordinary Share and one-fifth of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and deliver up to 4,600,000 redeemable warrants
        (including up to 600,000 redeemable warrants subject to the Over-allotment Option) to public investors in the Offering (the “Public Warrants” and, together with the Private Placement
        Warrants and the Forward Purchase Warrants, the “Warrants”).  Each whole Warrant entitles the holder thereof to purchase one Class A ordinary share of the Company, par value $0.0001 per
        share (the “Ordinary Shares”), for $11.50 per share, subject to adjustment as described herein.  Only whole Warrants are exercisable.  A holder of the Public Warrants will not be able to
        exercise any fraction of a Warrant; and

      

      

      
        1

        
          

      

      

      

      WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-25240, and a
        prospectus (the “Prospectus”), for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the
        Units, the Public Warrants and the Ordinary Shares included in the Units; and

      

      

      WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of
        the Warrants; and

      

      

      WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the
        Company, the Warrant Agent and the holders of the Warrants; and

      

      

      WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent (if a physical
        certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

      

      

      NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

      

      

      1. Appointment of Warrant Agent.  The Company hereby appoints the Warrant Agent to act as agent for the
          Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

      

      

      2. Warrants.

      

      

      2.1 Form of Warrant.  Each Warrant shall initially be issued in registered form only.

      

      

      2.2 Effect of Countersignature.  If a physical certificate is issued, unless and until countersigned by
          the Warrant Agent pursuant to this Agreement, a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

      

      

      2.3 Registration.

      

      

      2.3.1 Warrant Register.  The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original issuance and the registration of transfer of the Warrants.  Upon the initial issuance of the Warrants in
          book-entry form, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company.  Ownership
          of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained by institutions that have accounts with The Depository Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account, a “Participant”).

      

      

      If the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry
        settlement.  In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to
        the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants, which shall be in the form annexed
        hereto as Exhibit A.

      

      

      
        2

        
          

      

      

      

      Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the Chairman of the Board and the Chief Executive Officer or other principal officer of the Company.  In the event the person
        whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be
        such at the date of issuance.

      

      

      2.3.2 Registered Holder.  Prior to due presentment for registration of transfer of any Warrant, the
          Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby, for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any
          notice to the contrary.

      

      

      2.4 Detachability of Warrants.  The Ordinary Shares and Public Warrants comprising the Units shall begin
          separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or earlier (the “Detachment Date”) with the consent of Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, but in no event shall the Ordinary Shares and the Public Warrants
          comprising the Units be separately traded until (A) the Company has filed a Current Report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including
          the proceeds then received by the Company from the exercise by the underwriters of their right to purchase additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing of the Current Report on Form 8-K, and (B) the Company issues a press release announcing when such separate trading shall begin.

      

      

      2.5 Fractional Warrants.  The Company shall not issue fractional Warrants other than as part of the Units,
          each of which is comprised of one Ordinary Share and one-fifth of one whole Public Warrant.  If, upon the detachment of Public Warrants from the Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the
          Company shall round down to the nearest whole number the number of Warrants to be issued to such holder.

      

      

      2.6 Private Placement Warrants:  Forward Purchase Warrants.

      

      

      2.6.1 The Private Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any of its
          Permitted Transferees (as defined below), the Private Placement Warrants:  (i) may be exercised for cash or on a “cashless basis,” pursuant to subsection 3.3.1(c)
          hereof, (ii) including the Ordinary Shares issuable upon exercise of the Private Placement Warrants, may not be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination, (iii)
          shall not be redeemable by the Company pursuant to Section 6.1 hereof and (iv) shall only be redeemable by the Company pursuant to Section 6.2 if the Reference Value (as defined below) is less than $18.00 per share (subject to adjustment in compliance with Section 4 hereof); provided, however, that in the case of (ii), the Private Placement Warrants and any Ordinary Shares issued upon exercise of the Private Placement Warrants may be transferred by the holders thereof:

      

      

      (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members or partners
          of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates;

      

      

      (b) in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the
          individual’s immediate family, an affiliate of such person or to a charitable organization;

      

      

      (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual;

      

      

      
        3

        
          

      

      

      

      (d) in the case of an individual, pursuant to a qualified domestic relations order;

      

      

      (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the
          consummation of the Company’s Business Combination at prices no greater than the price at which the Private Placement Warrants or Ordinary Shares, as applicable, were originally purchased;

      

      

      (f) by virtue of the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor;

      

      

      (g) to the Company for no value for cancellation in connection with the consummation of our initial Business Combination;

      

      

      (h) in the event of the Company’s liquidation prior to the completion of its initial Business Combination; or

      

      

      (i) in the event of the Company’s completion of a liquidation, merger, share exchange or other similar transaction which results in all of the public
          shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the completion of the Company’s initial Business Combination; provided, however that, in the case of clauses (a) through (f), these permitted transferees (the “Permitted Transferees”) must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions in this Agreement.

      

      

      2.6.2 Forward Purchase Warrants.  The Forward Purchase Warrants shall have the same terms and be in the
          same form as the Private Placement Warrants.

      

      

      3. Terms and Exercise of Warrants.

      

      

      3.1 Warrant Price.  Each whole Warrant shall entitle the Registered Holder thereof, subject to the
          provisions of such Warrant and of this Agreement, to purchase from the Company the number of Ordinary Shares stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section
            4 hereof and in the last sentence of this Section 3.1.  The term “Warrant Price” as used in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted
          hereunder) described in the prior sentence at which Ordinary Shares may be purchased at the time a Warrant is exercised.  The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below)
          for a period of not less than fifteen Business Days (unless otherwise required by the Commission, any national securities exchange on which the Warrants are listed or applicable law); provided that the Company shall provide at least five days’
          prior written notice of such reduction to Registered Holders of the Warrants; and provided further, that any such reduction shall be identical among all of the Warrants.

      

      

      3.2 Duration of Warrants.  A Warrant may be exercised only during the period (the “Exercise Period”) (A) commencing on the later of:  (i) the date that is thirty (30) days after the first date on which the Company completes a
          Business Combination, and (ii) the date that is twelve (12) months from the date of the closing of the Offering, and (B) terminating at the earliest to occur of (x) 5:00 p.m., New York City time on the date that is five (5) years after the date
          on which the Company completes its initial Business Combination, (y) the liquidation of the Company in accordance with the Company’s amended and restated memorandum and articles of association, as amended from time to time, if the Company fails
          to complete a Business Combination, and (z) other than with respect to the Private Placement Warrants then held by the Sponsor or its Permitted Transferees with respect to a redemption pursuant to Section
            6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.2 hereof, 5:00 p.m., New York City time on the Redemption Date (as defined below) as provided in Section
            6.3 hereof (the “Expiration Date”); provided, however, that the exercise of any Warrant
          shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below, with respect to an effective registration statement or a
          valid exemption therefrom being available.  Except with respect to the right to receive the Redemption Price (as defined below) (other than with respect to a Private Placement Warrant then held by the Sponsor or its Permitted Transferees in
          connection with a redemption pursuant to Section 6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with
        Section 4 hereof), Section 6.2 hereof), in the event of a redemption (as set forth in
        Section 6 hereof), each Warrant (other than a Private Placement Warrant then held by the Sponsor or its Permitted Transferees in the event of a redemption pursuant to
        Section 6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section
            4 hereof) Section 6.2 hereof) not exercised on or before the Expiration Date shall become void, and all rights thereunder
          and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date.  The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided that
          the Company shall provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants.

      

      

      
        4

        
          

      

      

      

      3.3 Exercise of Warrants.

      

      

      3.3.1 Payment.  Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised
          by the Registered Holder thereof by delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, or, in the case of a Warrant represented by a book-entry, the
          Warrants to be exercised (the “Book-Entry, Warrants”) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such
          purposes in writing by the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (the “Election to Purchase”)
          any Ordinary Shares pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the Definitive Warrant Certificate or, in the case of a Book-Entry Warrant, properly delivered by the
          Participant in accordance with the Depositary’s procedures, and (iii) the payment in full of the Warrant Price for each Ordinary Share as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of
          the Warrant, the exchange of the Warrant for the Ordinary Shares and the issuance of such Ordinary Shares, as follows:

      

      

      (a) by wire transfer of immediately available funds in good certified check or good bank draft payable to the order of the Warrant Agent;

      

      

      (b) [Reserved];

      

      

      (c) with respect to any Private Placement Warrant, so long as such Private Placement Warrant is held by the Sponsor or a Permitted Transferee, by
          surrendering the Warrants for that number of Ordinary Shares equal to (i) if in connection with a redemption of Private Placement Warrants pursuant to Section 6.2
          hereof, as provided in Section 6.2 hereof with respect to a Make-Whole Exercise and (ii) in all other scenarios the quotient obtained by dividing (x) the product of
          the number of Ordinary Shares underlying the Warrants, multiplied by the excess of the “Sponsor Exercise Fair Market Value” (as
          defined in this subsection 3.3.1(c)) over the Warrant Price by (y) the Sponsor Exercise Fair Market Value.  Solely for purposes of this subsection 3.3.1(c) the “Sponsor Fair Market Value” shall mean the average last
          reported sale price of the Ordinary Shares for the ten (10) trading days ending on the third (3rd) trading day prior to the date on which notice of exercise of the Private Placement Warrant is sent to the Warrant Agent;

      

      

      (d) as provided in Section 6.2 hereof with respect to a Make-Whole
          Exercise; or

      

      

      (e) as provided in Section 7.4 hereof.

      

      

      3.3.2 Issuance of Ordinary Shares on Exercise.  As soon as practicable after the exercise of any Warrant
          and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of
          such Warrant a book-entry position or certificate, as applicable, for the number of Ordinary Shares to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it on the register of members of the
          Company, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares as to which such Warrant shall not have been exercised.  Notwithstanding the
          foregoing, the Company shall not be obligated to deliver any Ordinary Shares pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect
          to the Ordinary Shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations under Section 7.4 or a valid exemption from registration is available.  No Warrant shall be exercisable and the Company shall not be obligated to issue Ordinary Shares upon exercise of a Warrant unless the Ordinary Shares issuable upon
          such Warrant exercise have been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants.  Subject to Section 4.6 of this Agreement, a Registered Holder of Warrants may exercise its Warrants only for a whole number of Ordinary Shares.  The Company may require holders of Public Warrants to
          settle the Warrant on a “cashless basis” pursuant to Section 7.4.  If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would
          be entitled, upon the exercise of such Warrant, to receive a fractional interest in an Ordinary Share, the Company shall round down to the nearest whole number, the number of Ordinary Shares to be issued to such holder.

      

      

      
        5

        
          

      

      

      

      3.3.3 Valid Issuance.  All Ordinary Shares issued upon the proper exercise of a Warrant in conformity
          with this Agreement shall be validly issued, fully paid and nonassessable.

      

      

      3.3.4 Date of Issuance.  Each person in whose name any book-entry position or certificate, as applicable,
          for Ordinary Shares is issued and who is registered in the register of members of the Company shall for all purposes be deemed to have become the holder of record of such Ordinary Shares on the date on which the Warrant, or book-entry position
          representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date
          when the register of members of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the share
          transfer books or book-entry system are open.

      

      

      3.3.5 Maximum Percentage.  A holder of a Warrant may notify the Company in writing in the event it elects
          to be subject to the provisions contained in this subsection 3.3.5; however, no
          holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election.  If the election is made by a holder, the Warrant Agent
          shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the
          Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) (the “Maximum Percentage”) of the Ordinary Shares outstanding immediately after giving effect to such exercise.  For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially owned by such person and its affiliates
          shall include the number of Ordinary Shares issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude Ordinary Shares that would be issuable upon (x) exercise of the remaining,
          unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its
          affiliates (including, without limitation, any convertible notes or convertible preferred shares or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein.  Except as set forth in the preceding
          sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  For purposes of the Warrant, in determining the number of outstanding Ordinary Shares, the holder may rely on the number of outstanding Ordinary Shares as reflected in (1) the
          Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission as the case may be, (2) a more recent public announcement by the Company or (3) any other
          notice by the Company or Continental Stock Transfer & Trust Company, as transfer agent (in such capacity, the “Transfer Agent”),
          setting forth the number of Ordinary Shares outstanding.  For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number
          of Ordinary Shares then outstanding.  In any case, the number of issued and outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates
          since the date as of which such number of issued and outstanding Ordinary Shares was reported.  By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder
          to any other percentage specified in such notice; provided, however, that any such
          increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

      

      

      
        6

        
          

      

      

      

      4. Adjustments.

      

      

      4.1 Share Capitalizations.

      

      

      4.1.1 Sub-Divisions.  If after the date hereof, and subject to the provisions of Section 4.6 below, the number of issued and outstanding Ordinary Shares is increased by a capitalization or share dividend of Ordinary Shares, or by a sub-division of Ordinary
          Shares or other similar event, then, on the effective date of such share capitalization, sub-division or similar event, the number of Ordinary Shares issuable on exercise of each Warrant shall be increased in proportion to such increase in the
          issued and outstanding Ordinary Shares.  A rights offering made to all or substantially all holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than the “Historical Fair Market Value” (as defined below) shall
          be deemed a capitalization of a number of Ordinary Shares equal to the product of (i) the number of Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are
          convertible into or exercisable for the Ordinary Shares) multiplied by (ii) one (1) minus the quotient of (x) the price per Ordinary Share paid in such rights offering divided by (y) the Historical Fair Market Value.  For purposes of this subsection 4.1.1.  (i) if the rights offering is for securities convertible into or exercisable for Ordinary Shares, in determining the price payable for Ordinary Shares, there
          shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Historical Fair
          Market Value” means the volume weighted average price of the Ordinary Shares during the ten (10) trading day period ending on the trading day prior to the first date on which the Ordinary Shares trade on the
          applicable exchange or in the applicable market, regular way, without the right to receive such rights.  No Ordinary Shares shall be issued at less than their par value.

      

      

      4.1.2 Extraordinary Dividends.  If the Company, at any time while the Warrants are outstanding and
          unexpired, pays to all or substantially all of the holders of the Ordinary Shares a dividend or makes a distribution in cash, securities or other assets on account of such Ordinary Shares (or other shares into which the Warrants are convertible),
          other than (a) as described in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the
          Ordinary Shares in connection with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of the Ordinary Shares in connection with a shareholder vote to amend the Company’s amended and restated memorandum
          and articles of association (i) to modify the substance or timing of the Company’s obligation to provide holders of Ordinary Shares the right to have their shares redeemed in connection with the Company’s initial Business Combination or to redeem
          100% of the Company’s public shares if it does not complete its initial Business Combination within the time period required by the Company’s Amended and Restated Memorandum and Articles of Association, as amended from time to time, or (ii) with
          respect to any other provision relating to the rights of holders of Ordinary Shares, (e) as a result of the repurchase of Ordinary Shares by the Company if a proposed initial Business Combination is presented to the shareholders of the Company
          for approval or (f) in connection with the redemption of public shares upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded event
          being referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the
          effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the Company’s board of directors (the “Board”), in good faith) of any securities or other assets paid on each Ordinary Share in respect of such Extraordinary Dividend.  For purposes of this subsection 4.1.2.  “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share
          basis with the per share amounts of all other cash dividends and cash distributions paid on the Ordinary Shares during the 365-day period ending on the date of declaration of such dividend or distribution, does not exceed $0.50 per share (which
          amount shall be adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash
          distributions that resulted in an adjustment to the Warrant Price or to the number of Ordinary Shares issuable on exercise of each Warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less
          than $0.50.

      

      

      
        7

        
          

      

      

      

      4.2 Aggregation of Shares.  If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of issued and outstanding Ordinary Shares is decreased by a consolidation, combination, reverse share split or reclassification of Ordinary Shares
          or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of Ordinary Shares issuable on exercise of each Warrant shall be decreased in proportion to
          such decrease in issued and outstanding Ordinary Shares.

      

      

      4.3 Adjustments in Exercise Price.  Whenever the number of Ordinary Shares purchasable upon the exercise
          of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above,
          the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Ordinary Shares purchasable upon the exercise of the
          Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of Ordinary Shares so purchasable immediately thereafter.

      

      

      4.4 Raising of the Capital in Connection with the Initial Business Combination.  If (x) the Company issues
          additional Ordinary Shares or equity-linked securities, other than for the Forward Purchase Warrants and the Class A ordinary shares to be issued pursuant to the Forward Purchase Agreements, for capital raising purposes in connection with the
          closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Ordinary Share (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such
          issuance to the Sponsor or its affiliates, without taking into account any Class B ordinary shares, par value $0.0001 per share, of the Company held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
          thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Ordinary
          Shares during the twenty (20) trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per
          share redemption trigger price described in Section 6.1 and Section 6.2 shall be
          adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described in Section 6.2 shall be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

      

      

      4.5 Replacement of Securities upon Reorganization, etc.  In case of any reclassification or reorganization
          of the issued and outstanding Ordinary Shares (other than a change under Section 4.1 or Section 4.2 hereof or that solely affects the par value of such Ordinary Shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the
          Company is the continuing corporation and that does not result in any reclassification or reorganization of the issued and outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or
          other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms
          and conditions specified in the Warrants and in lieu of the Ordinary Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares or stock or other
          securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder
          had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided, however, that (i) if
          the holders of the Ordinary Shares were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other
          assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Ordinary Shares in such consolidation or
          merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Ordinary Shares (other than a tender, exchange or redemption offer made by the Company in
          connection with redemption rights held by shareholders of the Company as provided for in the Company’s amended and restated memorandum and articles of association or as a result of the repurchase of Ordinary Shares by the Company if a proposed
          initial Business Combination is presented to the shareholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning
          of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such
          affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 65% of the issued and outstanding Ordinary Shares, the holder of a Warrant shall be entitled to receive as the Alternative
          Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer,
          accepted such offer and all of the Ordinary Shares held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as
          possible to the adjustments provided for in this Section 4 provided, farther that
          if less than 70% of the consideration receivable by the holders of the Ordinary Shares in the applicable event is payable in the form of shares in the successor entity that is listed for trading on a national securities exchange or is quoted in
          an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the
          consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior
          to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below).  The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on
          Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”).  For purposes of calculating such amount, (i) Section 6 of this Agreement shall be taken into account, (ii) the price of each Ordinary Share shall be the volume weighted average price of the Ordinary Shares during the ten
          (10) trading day period ending on the trading day prior to the effective date of the applicable event, (iii) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day
          immediately prior to the day of the announcement of the applicable event and (iv) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant.  “Per Share Consideration” means (i) if the consideration paid to holders of the Ordinary Shares consists exclusively of cash, the amount of such
          cash per Ordinary Share, and (ii) in all other cases, the volume weighted average price of the Ordinary Shares during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event.  If any
          reclassification or reorganization also results in a change in Ordinary Shares covered by subsection 4.1.1. then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4.  The provisions of this Section 4.4
          shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers.  In no event shall the Warrant Price be reduced to less than the par value per share issuable upon exercise of such
          Warrant.

      

      

      
        8

        
          

      

      

      

      4.6 Notices of Changes in Warrant.  Upon every adjustment of the Warrant Price or the number of shares
          issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares
          purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.  Upon the occurrence of any event specified in Sections 4.1 4.2 4.3 4.4 or 4.5, the Company shall give written notice of the occurrence of such event to each holder
          of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event.  Failure to give such notice, or any defect therein, shall not affect the legality or validity of such
          event.

      

      

      4.7 No Fractional Shares.  Notwithstanding any provision contained in this Agreement to the contrary, the
          Company shall not issue fractional shares upon the exercise of Warrants.  If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant
          would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to such holder

      

      

      4.8 Form of Warrant.  The form of Warrant need not be changed because of any adjustment pursuant to this Section 4 and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant to this
          Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued
          or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

      

      

      5. Transfer and Exchange of Warrants.

      

      

      5.1 Registration of Transfer.  The Warrant Agent shall register the transfer, from time to time, of any
          outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer.  Upon any such transfer, a new Warrant
          representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent.  In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the
          Company from time to time upon request.

      

      

      5.2 Procedure for Surrender of Warrants.  Warrants may be surrendered to the Warrant Agent, together with
          a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of
          Warrants; provided, however, that except as otherwise provided herein or with respect to any Book-Entry Warrant, each Book-Entry Warrant may be transferred only in whole and only to the Depositary, to another nominee of the Depositary, to a
          successor depository, or to a nominee of a successor depository; provided further,
        however that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants), the Warrant Agent
          shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
          restrictive legend.

      

      

      5.3 Fractional Warrants.  The Warrant Agent shall not be required to effect any registration of transfer
          or exchange which shall result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

      

      

      5.4 Service Charges.  No service charge shall be made for any exchange or registration of transfer of
          Warrants.

      

      

      
        9

        
          

      

      

      

      5.5 Warrant Execution and Countersignature.  The Warrant Agent is hereby authorized to countersign and to
          deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5 and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly
          executed on behalf of the Company for such purpose.

      

      

      5.6 Transfer of Warrants.  Prior to the Detachment Date, the Public Warrants may be transferred or
          exchanged only together with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit.  Furthermore, each transfer of a Unit on the register relating to such
          Units shall operate also to transfer the Warrants included in such Unit.  Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on
          any transfer of Warrants on and after the Detachment Date.

      

      

      6. Redemption.

      

      

      6.1 Redemption of Warrants for Cash.  Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the
          Warrants, as described in Section 6.3 below, at a Redemption Price of $0.01 per Warrant, provided that (a) the Reference Value equals or exceeds $18.00 per share
          (subject to adjustment in compliance with Section 4 hereof) and (b) there is an effective registration statement covering the issuance of the Ordinary Shares
          issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3
          below).

      

      

      6.2 Redemption of Warrants for Ordinary Shares.  Subject to Section
            6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the
          Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Warrant, provided that (i) the Reference Value equals or
          exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof) and (ii) if the Reference Value is less than $18.00 per share (subject to
          adjustment in compliance with Section 4 hereof), the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding
          Public Warrants.  During the 30-day Redemption Period in connection with a redemption pursuant to this Section 6.2, Registered Holders of the Warrants may elect to
          exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of Ordinary Shares determined by reference to the table below, based
          on the Redemption Date (calculated for purposes of the table as the period to expiration of the Warrants) and the “Redemption Fair Market Value” (as such term is defined in this Section 6.2) (a “Make-Whole Exercise”).  Solely for purposes of this Section
            6.2, the “Redemption Fair Market Value” shall mean the volume weighted average price of
          the Ordinary Shares for the ten (10) trading days immediately following the date on which notice of redemption pursuant to this Section 6.2 is sent to the
          Registered Holders.  In connection with any redemption pursuant to this Section 6.2 the Company shall provide the Registered Holders with the Redemption Fair Market
          Value no later than one (1) Business Day after the ten (10) trading day period described above ends.

      
        10

        
          

      

      

      

       

      

      

      	
              Redemption Date

            	
              Redemption Fair Market Value of Ordinary Shares

              (period to expiration of warrants)

            
	
              
                <10.00

              

            	
              
                11.00

              

            	
              
                12.00

              

            	
              
                13.00

              

            	
              
                14.00

              

            	
              
                15.00

              

            	
              
                16.00

              

            	
              
                17.00

              

            	
              
                18.00

              

            
	
              60 months

            	
              0.261

            	
              0.280

            	
              0.297

            	
              0.311

            	
              0.324

            	
              0.337

            	
              0.348

            	
              0.358

            	
              0.361

            
	
              57 months

            	
              0.257

            	
              0.277

            	
              0.294

            	
              0.310

            	
              0.324

            	
              0.337

            	
              0.348

            	
              0.358

            	
              0.361

            
	
              54 months

            	
              0.252

            	
              0.272

            	
              0.291

            	
              0.307

            	
              0.322

            	
              0.335

            	
              0.347

            	
              0.357

            	
              0.361

            
	
              51 months

            	
              0.246

            	
              0.268

            	
              0.287

            	
              0.304

            	
              0.320

            	
              0.333

            	
              0.346

            	
              0.357

            	
              0.361

            
	
              48 months

            	
              0.241

            	
              0.263

            	
              0.283

            	
              0.301

            	
              0.317

            	
              0.332

            	
              0.344

            	
              0.356

            	
              0.361

            
	
              45 months

            	
              0.235

            	
              0.258

            	
              0.279

            	
              0.298

            	
              0.315

            	
              0.330

            	
              0.343

            	
              0.356

            	
              0.361

            
	
              42 months

            	
              0.228

            	
              0.252

            	
              0.274

            	
              0.294

            	
              0.312

            	
              0.328

            	
              0.342

            	
              0.355

            	
              0.361

            
	
              39 months

            	
              0.221

            	
              0.246

            	
              0.269

            	
              0.290

            	
              0.309

            	
              0.325

            	
              0.340

            	
              0.354

            	
              0.361

            
	
              36 months

            	
              0.213

            	
              0.239

            	
              0.263

            	
              0.285

            	
              0.305

            	
              0.323

            	
              0.339

            	
              0.353

            	
              0.361

            
	
              33 months

            	
              0.205

            	
              0.232

            	
              0.257

            	
              0.280

            	
              0.301

            	
              0.320

            	
              0.337

            	
              0.352

            	
              0.361

            
	
              30 months

            	
              0.196

            	
              0.224

            	
              0.250

            	
              0.274

            	
              0.297

            	
              0.316

            	
              0.335

            	
              0.351

            	
              0.361

            
	
              27 months

            	
              0.185

            	
              0.214

            	
              0.242

            	
              0.268

            	
              0.291

            	
              0.313

            	
              0.332

            	
              0.350

            	
              0.361

            
	
              24 months

            	
              0.173

            	
              0.204

            	
              0.233

            	
              0.260

            	
              0.285

            	
              0.308

            	
              0.329

            	
              0.348

            	
              0.361

            
	
              21 months

            	
              0.161

            	
              0.193

            	
              0.223

            	
              0.252

            	
              0.279

            	
              0.304

            	
              0.326

            	
              0.347

            	
              0.361

            
	
              18 months

            	
              0.146

            	
              0.179

            	
              0.211

            	
              0.242

            	
              0.271

            	
              0.298

            	
              0.322

            	
              0.345

            	
              0.361

            
	
              15 months

            	
              0.130

            	
              0.164

            	
              0.197

            	
              0.230

            	
              0.262

            	
              0.291

            	
              0.317

            	
              0.342

            	
              0.361

            
	
              12 months

            	
              0.111

            	
              0.146

            	
              0.181

            	
              0.216

            	
              0.250

            	
              0.282

            	
              0.312

            	
              0.339

            	
              0.361

            
	
              9 months

            	
              0.090

            	
              0.125

            	
              0.162

            	
              0.199

            	
              0.237

            	
              0.272

            	
              0.305

            	
              0.336

            	
              0.361

            
	
              6 months

            	
              0.065

            	
              0.099

            	
              0.137

            	
              0.178

            	
              0.219

            	
              0.259

            	
              0.296

            	
              0.331

            	
              0.361

            
	
              3 months

            	
              0.034

            	
              0.065

            	
              0.104

            	
              0.150

            	
              0.197

            	
              0.243

            	
              0.286

            	
              0.326

            	
              0.361

            
	
              0 months

            	
              -

            	
              -

            	
              0.042

            	
              0.115

            	
              0.179

            	
              0.233

            	
              0.281

            	
              0.323

            	
              0.361

            

      

      

      The exact Redemption Fair Market Value and Redemption Date may not be set forth in the table above, in which case, if the Redemption Fair Market Value is between two values in the table or the Redemption Date is
        between two redemption dates in the table, the number of Ordinary Shares to be issued for each Warrant exercised in a Make-Whole Exercise shall be determined by a straight-line interpolation between the number of shares set forth for the higher and
        lower Redemption Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as applicable.

      

      

      The share prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a Warrant or the Exercise Price is adjusted pursuant to Section
          4 hereof.  If the number of shares issuable upon exercise of a Warrant is adjusted pursuant to Section 4 hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior to such adjustment,
        multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Warrant as so
        adjusted.  The number of shares in the table above shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Warrant.  If the Exercise Price of a warrant is adjusted, (a) in the case of an
        adjustment pursuant to Section 4.4 hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior to such adjustment multiplied by a fraction, the numerator of which is the higher of the Market Value
        and the Newly Issued Price and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to Section 4.1.2 hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior to such
        adjustment less the decrease in the Exercise Price pursuant to such Exercise Price adjustment.  In no event shall the number of shares issued in connection with a Make-Whole Exercise exceed 0.361 Ordinary Shares per Warrant (subject to adjustment).

      

      

      6.3 Date Fixed for, and Notice of, Redemption; Redemption Price; Reference Value.  In the event that the
          Company elects to redeem the Warrants pursuant to Sections 6.1 or 6.2 the Company
          shall fix a date for the redemption (the “Redemption Date”).  Notice of redemption shall be mailed by first class mail, postage
          prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day Redemption Period”) to the
          Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books.  Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the
          Registered Holder received such notice.  As used in this Agreement, (a) “Redemption Price” shall mean the price per Warrant at which
          any Warrants are redeemed pursuant to Sections 6.1 or 6.2 and (b) “Reference Value” shall mean the last reported sales price of the Ordinary Shares for any twenty (20) trading days within the thirty (30)
          trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.

      

      

      
        11

        
          

      

      

      

      6.4 Exercise After Notice of Redemption.  The Warrants may be exercised, for cash (or on a “cashless
          basis” in accordance with Section 6.2 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.3 hereof and prior to the Redemption Date.  On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon
          surrender of the Warrants, the Redemption Price.

      

      

      6.5 Exclusion of Private Placement Warrants and Forward Purchase Warrants.  The Company agrees that (a)
          the redemption rights provided in Section 6.1 hereof shall not apply to (x) the Private Placement Warrants if at the time of the redemption such Private Placement
          Warrants continue to be held by the Sponsor or its Permitted Transferees or (y) the Forward Purchase Warrants if at the time of the redemption such Forward Purchase Warrants continue to be held by the Forward Purchase Investor or its Permitted
          Transferees, and (b) if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), the redemption rights
          provided in Section 6.2 hereof shall not apply to (x) the Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be
          held by the Sponsor or its Permitted Transferees or (y) the Forward Purchase Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Forward Purchase Investor or its Permitted Transferees.  However,
          once such Private Placement Warrants or Forward Purchase Warrants are transferred (other than to Permitted Transferees in accordance with Section 2.6 hereof), the
          Company may redeem the Private Placement Warrants and Forward Purchase Warrants pursuant to Section 6.1 or 6.2 hereof, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants and Forward Purchase Warrants to exercise the Private Placement Warrants and Forward
          Purchase Warrants prior to redemption pursuant to Section 6.4 hereof.  Private Placement Warrants and Forward Purchase Warrants that are transferred to persons
          other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants or Forward Purchase Warrants, and shall become Public Warrants under this Agreement, including for purposes of Section
            9.8 hereof.

      

      

      7. Other Provisions Relating to Rights of Holders of Warrants.

      

      

      7.1 No Rights as Shareholder.  A Warrant does not entitle the Registered Holder thereof to any of the
          rights of a shareholder of the Company, including, without limitation, the right to receive dividends, or other distributions, to exercise any preemptive rights to vote or to consent or to receive notice as shareholders in respect of the meetings
          of shareholders or the election of directors of the Company or any other matter.

      

      

      7.2 Lost, Stolen, Mutilated, or Destroyed Warrants.  If any Warrant is lost, stolen, mutilated, or
          destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like
          denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed.  Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed
          Warrant shall be at any time enforceable by anyone.

      

      

      7.3 Reservation of Ordinary Shares.  The Company shall at all times reserve and keep available a number of
          its authorized but unissued Ordinary Shares that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

      

      

      
        12

        
          

      

      

      

      7.4 Registration of Ordinary Shares; Cashless Exercise at Company’s Option.

      

      

      7.4.1 Registration of the Ordinary Shares.  The Company agrees that as soon as practicable, but in no
          event later than twenty (20) Business Days after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration statement for the registration, under the Securities
          Act, of the Ordinary Shares issuable upon exercise of the Warrants.  The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) Business Days following the closing of its initial Business
          Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement.  If any such
          registration statement has not been declared effective by the sixtieth (60) Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the sixty-first (611)
          Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective
          registration statement covering the issuance of the Ordinary Shares issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act or
          another exemption) for that number of Ordinary Shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Warrants, multiplied by the excess of the “Fair Market Value” (as
          defined below) over the Warrant Price by (y) the Fair Market Value and (B) 0.361.  Solely for purposes of this subsection 7.4.1 “Fair Market Value” shall mean the volume-weighted average price of the Ordinary Shares as reported during the ten (10) trading day period ending on the trading day
          prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary.  The date that notice of “cashless exercise” is received by the Warrant Agent shall be
          conclusively determined by the Warrant Agent.  In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law
          firm with securities law experience) stating that (i) the exercise of the Warrants on a “cashless basis” in accordance with this subsection 7.4.1 is not required to
          be registered under the Securities Act and (ii) the Ordinary Shares issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the
          Securities Act) of the Company and, accordingly, shall not be required to bear a restrictive legend.  Except as provided in subsection 7.4.2, for the avoidance of
          doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection
            7.4.1.

      

      

      7.4.2 Cashless Exercise at Company’s Option.  If the Ordinary Shares are at the time of any exercise of a
          Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, (i) require holders of Public Warrants who
          exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Ordinary Shares issuable upon exercise of
          the Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify for sale the Ordinary Shares issuable upon exercise of the Public Warrant under applicable blue sky
          laws to the extent an exemption is not available.

      

      

      8. Concerning the Warrant Agent and Other Matters.

      

      

      8.1 Payment of Taxes.  The Company shall from time to time promptly pay all taxes and charges that may be
          imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

      

      

      
        13

        
          

      

      

      

      8.2 Resignation, Consolidation, or Merger of Warrant Agent.

      

      

      8.2.1 Appointment of Successor Warrant Agent.  The Warrant Agent, or any successor to it hereafter
          appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company.  If the office of the Warrant Agent becomes vacant by resignation or incapacity
          to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent.  If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of
          such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the
          State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost.  Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized
          and existing under the laws of the State of New York, in good standing and having its principal office in the United States of America, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by
          federal or state authority.  After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as
          Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such
          successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in
          writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

      

      

      8.2.2 Notice of Successor Warrant Agent.  In the event a successor Warrant Agent shall be appointed, the
          Company shall give notice thereof to the predecessor Warrant Agent and the Transfer Agent for the Ordinary Shares not later than the effective date of any such appointment.

      

      

      8.2.3 Merger or Consolidation of Warrant Agent.  Any entity into which the Warrant Agent may be merged or
          with which it may be consolidated or any entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act.

      

      

      8.3 Fees and Expenses of Warrant Agent.

      

      

      8.3.1 Remuneration.  The Company agrees to pay the Warrant Agent reasonable remuneration for its services
          as such Warrant Agent hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

      

      

      8.3.2 Further Assurances.  The Company agrees to perform, execute, acknowledge, and deliver or cause to
          be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

      

      

      8.4 Liability of Warrant Agent.

      

      

      8.4.1 Reliance on Company Statement.  Whenever in the performance of its duties under this Agreement, the
          Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein
          specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chairman of the Board and Chief Executive Officer of the Company and delivered to the Warrant Agent.  The Warrant Agent may rely upon
          such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

      

      

      
        14

        
          

      

      

      

      8.4.2 Indemnity.  The Warrant Agent shall be liable hereunder only for its own gross negligence, willful
          misconduct, fraud or bad faith.  The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by
          the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

      

      

      8.4.3 Exclusions.  The Warrant Agent shall have no responsibility with respect to the validity of this
          Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof).  The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in
          any Warrant.  The Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner,
          method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or
          reservation of any Ordinary Shares to be issued pursuant to this Agreement or any Warrant or as to whether any Ordinary Shares shall, when issued, be valid and fully paid and nonassessable.

      

      

      8.5 Acceptance of Agency.  The Warrant Agent hereby accepts the agency established by this Agreement and
          agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received
          by the Warrant Agent for the purchase of Ordinary Shares through the exercise of the Warrants.

      

      

      8.6 Waiver.  The Warrant Agent has no right of set-off or any other right, title, interest or claim of any
          kind (“Claim”) in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement,
          dated as of the date hereof, by and between the Company and Continental Stock Transfer & Trust Company as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust
          Account for any reason whatsoever.  The Warrant Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

      

      

      9. Miscellaneous Provisions.

      

      

      9.1 Successors.  All the covenants and provisions of this Agreement by or for the benefit of the Company
          or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns.

      

      

      9.2 Notices.  Any notice, statement or demand authorized by this Agreement to be given or made by the
          Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such
          notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

      

      

      LDH Growth Corp I

      600 Brickell Avenue, Suite 2650

      Miami, Florida 33138

      Attention:  Legal

      

      

      with a copy to:

      

      

      Gibson, Dunn & Crutcher LLP

      200 Park Avenue

      New York, NY 10166

      Attention:  Andrew Fabens & Evan D’Amico

      Email: Afabens@gibsondunn.com; EDAmico@gibsondunn.com

      

      

      
        15

        
          

      

      

      

      Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent
        by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

      

      

      Continental Stock Transfer & Trust Company

      One State Street, 30th Floor

      New York, NY 10004

      Attention:  Compliance Department

      

      

      9.3 Applicable Law and Exclusive Forum.  The validity, interpretation, and performance of this Agreement
          and of the Warrants shall be governed in all respects by the laws of the State of New York.  Subject to applicable law, the Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this
          Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive forum
          for any such action, proceeding or claim.  The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.  Notwithstanding the foregoing, the provisions of this paragraph will not
          apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum.

      

      

      Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3.  If any action, the subject matter of which is
        within the scope the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to:  (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States
        District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having
        service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

      

      

      9.4 Persons Having Rights under this Agreement.  Nothing in this Agreement shall be construed to confer
          upon, or give to, any person, corporation or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation,
          promise, or agreement hereof.  All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered
          Holders of the Warrants.

      

      

      9.5 Examination of the Warrant Agreement.  A copy of this Agreement shall be available at all reasonable
          times at the office of the Warrant Agent in the United States of America, for inspection by the Registered Holder of any Warrant.  The Warrant Agent may require any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

      

      

      9.6 Counterparts.  This Agreement may be executed in any number of original or facsimile counterparts and
          each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

      

      

      9.7 Effect of Headings.  The section headings herein are for convenience only and are not part of this
          Agreement and shall not affect the interpretation thereof.

      

      

      
        16

        
          

      

      

      

      9.8 Amendments.  This Agreement may be amended by the parties hereto without the consent of any Registered
          Holder for the purpose of (i) curing any ambiguity or correcting any mistake, including to conform the provisions hereof to the description of the terms of the Warrants and this Agreement set forth in the Prospectus, or defective provision
          contained herein, (ii) amending the definition of “Ordinary Cash Dividend” as contemplated by and in accordance with the second sentence of subsection 4.1.2 or
          (iii) adding or changing any provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the rights of the Registered Holders
          under this Agreement.  All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the Private Placement Warrants, shall
          require the vote or written consent of the Registered Holders of 65% of the then-outstanding Public Warrants and, solely with respect to any amendment to the terms of the Private Placement Warrants or any provision of this Agreement with respect
          to the Private Placement Warrants, 65% of the then-outstanding Private Placement Warrants, and, solely with respect to any amendment to the terms of the Forward Purchase Warrants or any provision of this Agreement with respect to the Forward
          Purchase Warrants, 65% of the then-outstanding Forward Purchase Warrants.  Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections
            3.1 and 3.2, respectively, without the consent of the Registered Holders.

      

      

      9.9 Severability.  This Agreement shall be deemed severable, and the invalidity or unenforceability of any
          term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof.  Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that
          there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

      

      

      Exhibit A — Form of Warrant Certificate

      

      

      Exhibit B — Legend

      

      

      
        17

        
          

      

      

      

      IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

      

      

      	 	
              Very truly yours,

            
	 	 
	 	
              LDH GROWTH CORP I

            
	 	 
	 	
              By:

            	
              /s/ Michel Combes

            
	 	 	
              Name: Michel Combes

              Title: President

            

      

      

      	 	 
	 	
              CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

            
	 	 
	 	
              By:

            	
              /s/ Henry Farrell

            
	 	 	
              Name: Henry Farrell

              Title: Vice President

            

      

      

      

      

      [Signature Page to Warrant Agreement]

      

      

      
        
          

      

      
      

      

      EXHIBIT A

      

      

      [FACE]

      

      

      Number

      

      

      Warrants

      

      

      THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

      THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

      IN THE WARRANT AGREEMENT DESCRIBED BELOW

      

      

      LDH Growth Corp I

      Incorporated Under the Laws of the Cayman Islands

      

      

      CUSIP [•]

      

      

      Warrant Certificate

      

      

      This Warrant Certificate certifies that [•], or registered assigns, is the registered holder of [ ] warrant(s) (the “Warrants”
        and each, a “Warrant”) to purchase Class A ordinary shares, $0.0001 par value per share (the “Ordinary Shares”), LDH Growth Corp
        I, a Cayman Islands exempted company (the “Company”).  Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive
        from the Company that number of fully paid and nonassessable Ordinary Shares as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant
        Agreement, payable in lawful money (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and
        payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement.  Defined terms used in this Warrant Certificate but not defined herein shall have
        the meanings given to them in the Warrant Agreement.

      

      

      Each whole Warrant is initially exercisable for one fully paid and non-assessable Ordinary Share.  Fractional shares shall not be issued upon exercise of any Warrant.  If, upon the exercise of Warrants, a holder would
        be entitled to receive a fractional interest in an Ordinary Share, the Company shall, upon exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to the Warrant holder.  The number of Ordinary Shares issuable
        upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events as set forth in the Warrant Agreement.

      

      

      The initial Exercise Price per one Ordinary Share for any Warrant is equal to $11.50 per share.  The Exercise Price is subject to adjustment upon the occurrence of certain events as set forth in the Warrant Agreement.

      

      

      Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become
        void.  The Warrants may be redeemed, subject to certain conditions as set forth in the Warrant Agreement.

      

      

      Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this
        place.

      

      

      
        A-1

        
          

      

      

      

      This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.  This Warrant Certificate shall be governed by and construed in accordance with the
        internal laws of the State of New York.

      

      

      	 	
              LDH GROWTH CORP I

            
	 	 	 
	 	
              By:

            	 
	 	 	
              Name:

            
	 	 	
              Title: Chairman and Chief Executive Officer

            
	 	 	 
	 	
              CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT

            
	 	 	 
	 	
              By:

            	 
	 	 	
              Name:

            
	 	 	
              Title:

            

      

      

      
        A-2

        
          

      

      

      

      [Form of Warrant Certificate]

      

      

      [Reverse]

      

      

      The Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive [ ] Ordinary Shares and are issued or to be issued pursuant to a Warrant
        Agreement dated as of [•], 2021 (the “Warrant Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York limited purpose trust
        company, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a
        description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder” meaning the Registered Holders or Registered Holder, respectively) of the Warrants.  A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the
        Company.  Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

      

      

      Warrants may be exercised at any time during the Exercise Period set forth in the Warrant Agreement.  The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant
        Certificate, with the form of Election to Purchase set forth hereon properly completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise”
        as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent.  In the event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of
        Warrants evidenced hereby, there shall be issued to the holder hereof, or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

      

      

      Notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the issuance of the Ordinary Shares
        to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to the Ordinary Shares is current, except through “cashless exercise” as provided for in the Warrant
        Agreement.

      

      

      The Warrant Agreement provides that upon the occurrence of certain events the number of Ordinary Shares issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be
        adjusted.  If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in an Ordinary Share, the Company shall, upon exercise, round down to the nearest whole number of Ordinary Shares to be issued to the
        holder of the Warrant.

      

      

      Warrant Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be
        exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of
        Warrants.

      

      

      
        A-3

        
          

      

      

      

      Upon due presentation for registration of transfer of this Warrant Certificate at the office of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like
        number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection
        therewith.

      

      

      The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by
        anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.  Neither the Warrants nor this
        Warrant Certificate entitles any holder hereof to any rights of a shareholder of the Company.

      

      

      
        A-4

        
          

      

      

      

      Election to Purchase

      

      

      (To Be Executed Upon Exercise of Warrant)

      

      

      The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive [ ] Ordinary Shares and herewith tenders payment for such Ordinary Shares to the order of LDH Growth
        Corp I  (the “Company”) in the amount of $[ ] in accordance with the terms hereof.  The undersigned requests that the register of members of the Company be updated to reflect the issuance
        of such Ordinary Shares in the name of the undersigned and a certificate for such Ordinary Shares be registered in the name of [ ], whose address is [ ] and that such Ordinary Shares be delivered to [ whose address is [ ].  If said [ ] number of
        Ordinary Shares is less than all of the Ordinary Shares purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name of [ ], whose address is [ ]
        and that such Warrant Certificate be delivered to [ ], whose address is [ ].

      

      

      In the event that the Warrant has been called for redemption by the Company pursuant to Section 6.2 of the Warrant Agreement and a holder thereof elects to exercise its Warrant pursuant to a Make-Whole
        Exercise, the number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) or Section 6.2 of the Warrant Agreement, as applicable.

      

      

      In the event that the Warrant is a Private Placement Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of Ordinary Shares that this
        Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement.

      

      

      In the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of Ordinary Shares that this Warrant is exercisable for shall be determined in
        accordance with Section 7.4 of the Warrant Agreement.

      

      

      In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of Ordinary Shares that this Warrant is exercisable for would be determined in
        accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the following:  The undersigned hereby irrevocably elects to exercise the right, represented by this
        Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive Ordinary Shares.  If said number of shares is less than all of the Ordinary Shares purchasable hereunder (after giving effect to the cashless
        exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name of [ ], whose address is [ ] and that such Warrant Certificate be delivered to [ ], whose
        address is [ ].

      

      

      [Signature Page Follows]

      

      

      
        A-5

        
          

      

      

      

      Date:  [ ], 20

      

      

      (Signature)

      

      

      (Address)

      

      

      _______________________________________

      (Tax Identification Number)

      

      

      Signature Guaranteed:

      

      

      _____________

      

      

      THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM,
        PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED).

      

      

      
        A-6

        
          

      

      

      

      EXHIBIT B

      

      

      LEGEND

      

      

      THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED
        UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE.  IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG
        LDH GROWTH CORP I  (THE “COMPANY”), LDH SPONSOR LLC AND THE OTHER PARTIES THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS
        THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE
        WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

      

      

      SECURITIES EVIDENCED BY THIS CERTIFICATE AND CLASS A ORDINARY SHARES OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT TO BE EXECUTED BY THE
        COMPANY.

      

      

      NO. [ ] WARRANT

      

      

    

  

  B-1Exhibit 10.1

      

      

      March 18, 2021

      

      

      LDH Growth Corp I

      600 Brickell Avenue, Suite 2650

      Miami

      Florida 33138, United States

      

      

      Re:  Initial Public Offering

      

      

      Ladies and Gentlemen:

      

      

      This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among LDH Growth Corp I, a Cayman Islands exempted company (the “Company”), Citigroup Global Markets Inc., and JP Morgan Securities LLC (the “Underwriters”), relating to an
        underwritten initial public offering (the “Public Offering”) of 20,000,000 of the Company’s units (or 23,000,000 units that may be purchased if the
        Underwriters’ option to purchase additional units is exercised, the “Units”), each comprising of one of the Company’s Class A ordinary shares, par
        value $0.0001 per share (the “Ordinary Shares”), and one-fifth of one redeemable warrant (each whole warrant, a “Warrant”).  Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment.  The Units will be sold in the Public
        Offering pursuant to a registration statement on Form S-1 and a prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and
        Exchange Commission (the “Commission”).  Certain capitalized terms used herein are defined in paragraph 1 hereof.

      

      

      In order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, LDH
        Sponsor LLC (the “Sponsor”) and each of the undersigned (each, an “Insider” and, collectively, the “Insiders”) hereby agree with the Company as follows:

      

      

      1.          Definitions.  As used herein, (i) “Business

          Combination” shall mean a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities; (ii) “Forward Purchase Agreement’ shall mean that certain forward purchase agreement entered into between the Company and the Sponsor (the “Forward Purchaser”), pursuant to which the Forward Purchaser will purchase units for up to an aggregate purchase price of $50,000,000 with each unit
        consisting of one Ordinary Share and one-fifth of one Warrant to purchase one Ordinary Share at $11.50 per share, for a purchase price of $10.00 per Unit in a transaction to occur concurrently with the closing of the initial Business Combination;
        (iii) “Founder Shares” shall mean the 5,750,000 Class B ordinary shares of the Company, par value $0.0001 per share, outstanding prior to the
        consummation of the Public Offering and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time of our initial Business Combination or earlier at the option of the holders thereof;
        (iv) “Private Placement Warrants” shall mean the warrants to purchase Ordinary Shares of the Company that will be acquired by the Sponsor for an
        aggregate purchase price of $7,300,000 (or up to $7,900,000 if the Underwriters exercise their option to purchase additional units), or $1.50 per Warrant, in a private placement that shall close simultaneously with the consummation of the Public
        Offering (including Ordinary Shares issuable upon conversion thereof); (v) “Public Shareholders” shall mean the holders of Ordinary Shares included
        in the Units issued in the Public Offering; (vi) “Public Shares” shall mean the Ordinary Shares included in the Units issued in the Public
        Offering; (vii) “Trust Account” shall mean the trust account into which a portion of the net proceeds of the Public Offering and the sale of the
        Private Placement Warrants shall be deposited; (viii) “Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell,
        hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call
        equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other
        arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public
        announcement of any intention to effect any transaction specified in clause (a) or (b); and (ix) “Charter” shall mean the Company’s Amended and
        Restated Memorandum and Articles of Association, as the same may be amended from time to time.

      

      

      
        1

        
          

      

      

      

      2.          Representation and Warranties.

      

      

      (a)          The Sponsor and each Insider, with respect to itself, herself or himself, represent and warrant to the Company that it, she or he has the full right and power,
          without violating any agreement to which it, she or he is bound (including, without limitation, any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement, as applicable, and to
          serve as an officer of the Company and/or a director on the Company’s Board of Directors (the “Board”), as applicable, and each
          Insider hereby consents to being named in the Prospectus, road show and any other materials as an officer and/or director of the Company, as applicable.

      

      

      (b)          Each Insider represents and warrants, with respect to itself, herself or himself, that such Insider’s biographical information furnished to the Company (including
          any such information included in the Prospectus) is true and accurate in all material respects and does not omit any material information with respect to such Insider’s background.  The Insider’s questionnaire furnished to the Company is true and
          accurate in all material respects.  Each Insider represents and warrants that such Insider is not subject to or a respondent in any legal action for any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act
          or practice relating to the offering of securities in any jurisdiction; such Insider has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial transaction or handling of funds of another
          person, or (iii) pertaining to any dealings in any securities and such Insider is not currently a defendant in any such criminal proceeding; and such Insider has never been suspended or expelled from membership in any securities or commodities
          exchange or association or had a securities or commodities license or registration denied, suspended or revoked.

      

      

      3.          Business Combination Vote.  It is acknowledged and agreed that the Company shall not
          enter into a definitive agreement regarding a proposed Business Combination without the prior consent of the Sponsor.  The Sponsor and each Insider, with respect to itself or herself or himself, agrees that if the Company seeks shareholder
          approval of a proposed initial Business Combination, then in connection with such proposed initial Business Combination, it, she or he, as applicable, shall vote all Founder Shares and any Public Shares held by it, her or him, as applicable, in
          favor of such proposed initial Business Combination (including any proposals recommended by the Board in connection with such Business Combination) and not redeem any Public Shares held by it, her or him, as applicable, in connection with such
          shareholder approval.

      

      

      4.          Failure to Consummate a Business Combination:  Trust Account Waiver.

      

      

      (a)          The Sponsor and each Insider hereby agree, with respect to itself, herself or himself, that in the event that the Company fails to consummate its initial Business
          Combination within the time period set forth in the Charter, the Sponsor and each Insider shall take all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably
          possible but not more than 10 business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in
          the Trust Account and not previously released to the Company to pay income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish
          Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining
          shareholders and the Board, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of
          applicable law.  The Sponsor and each Insider agree not to propose any amendment to the Charter (i) that would modify the substance or timing of the Company’s obligation to provide holders of the Public Shares the right to have their shares
          redeemed in connection with an initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the required time period set forth in the Charter or (ii) with respect to
          any provision relating to the rights of holders of Public Shares, unless the Company provides its Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash,
          equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, if any, divided by the number of then outstanding Public
          Shares.

      

      

      
        2

        
          

      

      

      

      (b)          The Sponsor and each Insider, with respect to itself, herself or himself, acknowledges that it, she or he has no right, title, interest or claim of any kind in or to
          any monies held in the Trust Account or any other asset of the Company as a result of any liquidation of the Company with respect to the Founder Shares held by it, her or him, if any.  The Sponsor and each of the Insiders hereby further waive,
          with respect to any Founder Shares and Public Shares held by it, her or him, as applicable, any redemption rights it, she or he may have in connection with the consummation of a Business Combination, including, without limitation, any such rights
          available in the context of a shareholder vote to approve such Business Combination or a shareholder vote to approve an amendment to the Charter (i) that would modify the substance or timing of the Company’s obligation to provide holders of the
          Public Shares the right to have their shares redeemed in connection with an initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the time period set forth in
          the Charter or (ii) with respect to any provision relating to the rights of holders of Public Shares (although the Sponsor and the Insiders shall be entitled to liquidation rights with respect to any Public Shares they hold if the Company fails
          to consummate a Business Combination within the required time period set forth in the Charter).

      

      

      5.          Lock-up:  Transfer Restrictions.

      

      

      (a)          The Sponsor and the Insiders agree that they shall not Transfer any Founder Shares (the “Founder

          Shares Lock-up”) until the earliest of (A) one year after the completion of an initial Business Combination and (B) the date following the completion of an initial Business Combination on which the Company
          completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property (the “Founder Shares Lock-up Period”).  Notwithstanding the foregoing, if, subsequent to a Business Combination, the last reported sale price of the
          Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing at least 150 days
          after the Company’s initial Business Combination, the Founder Shares shall be released from the Founder Shares Lock-up.

      

      

      (b)          The Insiders agree that they shall not Transfer, without the prior written consent of each of the underwriters, any Units, Warrants or Ordinary Shares they purchased
          from the Public Offering for a period of 180 days after the date of the prospectus.

      

      

      (c)          The Sponsor and Insiders agree that they shall not effectuate any Transfer of Private Placement Warrants or Ordinary Shares underlying such warrants until 30 days
          after the completion of an initial Business Combination.

      

      

      (d)          Notwithstanding the provisions set forth in paragraphs 5(a) and (b),Transfers of the Founder Shares, Private Placement Warrants and Ordinary Shares underlying the Private Placement Warrants are permitted (a) to the Company’s officers or
          directors, any affiliate or family member of any of the Company’s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates; (b) in the case of an
          individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an
          individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation
          of a Business Combination at prices no greater than the price at which the Founder Shares, Private Placement Warrants or Ordinary Shares, as applicable, were originally purchased; (f) by virtue of the Sponsor’s organizational documents upon
          liquidation, winding up or dissolution of the Sponsor; (g) to the Company for no value for cancellation in connection with the consummation of an initial Business Combination, (h) in the event of the Company’s liquidation prior to the completion
          of a Business Combination; or (i) in the event of completion of a liquidation, merger, share exchange or other similar transaction which results in all of the Company’s Public Shareholders having the right to exchange their Ordinary Shares for
          cash, securities or other property subsequent to the completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions.

      

      

      
        3

        
          

      

      

      

      (e)          During the period commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the Sponsor and each Insider shall not, without
          the prior written consent of the Underwriters, Transfer any Units, Ordinary Shares, Warrants or any other securities convertible into, or exercisable or exchangeable for, Ordinary Shares held by it, her or him, as applicable, subject to certain
          exceptions enumerated in Section 5(e) of the Underwriting Agreement.

      

      

      6.          Remedies.  The Sponsor and each of the Insiders hereby agree and acknowledge that
          (i) each of the Underwriters and the Company would be irreparably injured in the event of a breach by the Sponsor or such Insider of its, her or his obligations, as applicable under paragraphs 3, 4, 5, 7, 10 and 11.  (ii) monetary damages may not
          be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

      

      

      7.          Payments by the Company.  Except as disclosed in the Prospectus, neither the Sponsor
          nor any affiliate of the Sponsor nor any director or officer of the Company nor any affiliate of the directors and officers shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any payment of a loan
          or other compensation prior to, or in connection with any services rendered in order to effectuate the consummation of the Company’s initial Business Combination (regardless of the type of transaction that it is).

      

      

      8.          Director and Officer Liability Insurance.  The Company will maintain an insurance
          policy or policies providing directors’ and officers’ liability insurance, and the Insiders shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any of the
          Company’s directors or officers.

      

      

      9.          Termination.  This Letter Agreement shall terminate on the earlierof (i) the
          expiration of the Founder Shares Lock-up Period and (ii) the liquidation of the Company.

      

      

      10.          Indemnification.  In the event of the liquidation of the Trust Account upon the
          failure of the Company to consummate its initial Business Combination within the time period set forth in the Charter, the Sponsor (the “Indemnitor”) agrees to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever
          (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened) to which the Company may become subject as a result of any
          claim by (i) any third party for services rendered or products sold to the Company (except for the Company’s independent auditors) or (ii) any prospective target business with which the Company has discussed entering into a transaction agreement
          (a “Target”) provided, however, that
          such indemnification of the Company by the Indemnitor (x) shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to the Company or a Target do not reduce the amount of funds in
          the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to
          reductions in the value of the trust assets, in each case net of interest that may be withdrawn to pay the Company’s tax obligations, (y) shall not apply to any claims by a third party or Target who executed a waiver of any and all rights to the
          monies held in the Trust Account (whether or not such waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of
          1933, as amended.  The Indemnitor shall have the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Indemnitor, the
          Indemnitor notifies the Company in writing that it shall undertake such defense.

      

      

      
        4

        
          

      

      

      

      11.          Forfeiture of Founder Shares.  To the extent that the Underwriters do not exercise
          their option to purchase additional Units within 45 days from the date of the Prospectus in full (as further described in the Prospectus), the Sponsor agrees to automatically surrender to the Company for no consideration, for cancellation at no
          cost, an aggregate number of Founder Shares so that the number of Founder Shares will equal 20% of the sum of the total number of issued and outstanding Ordinary Shares after the Public Offering (excluding the number of Ordinary Shares be sold
          pursuant to the Forward Purchase Agreement).  The Sponsor and Insiders further agree that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a share capitalization or a share repurchase, as
          applicable, with respect to the Founder Shares immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20% of the sum of the total number of issued and outstanding Ordinary Shares
          at such time (excluding the number of Ordinary Shares to be sold pursuant to the Forward Purchase Agreement).

      

      

      12.          Entire Agreement.  This Letter Agreement constitutes the entire agreement and
          understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the
          subject matter hereof or the transactions contemplated hereby.  This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument
          executed by all parties hereto.

      

      

      13.          Assignment.  No party hereto may assign either this Letter Agreement or any of its
          rights, interests, or obligations hereunder without the prior written consent of the other parties.  Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or
          title to the purported assignee.  This Letter Agreement shall be binding on the Sponsor, each of the Insiders and each of their respective successors, heirs, personal representatives and assigns and permitted transferees.

      

      

      14.          Counterparts.  This Letter Agreement may be executed in any number of original or
          facsimile counterparts, and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

      

      

      15.          Effect of Headings.  The paragraph headings herein are for convenience only and are
          not part of this Letter Agreement and shall not affect the interpretation thereof.

      

      

      16.          Severability.  This Letter Agreement shall be deemed severable, and the invalidity
          or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof.  Furthermore, in lieu of any such invalid or unenforceable term or provision,
          the parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

      

      

      
        5

        
          

      

      

      

      17.          Governing Law.  This Letter Agreement shall be governed by and construed and
          enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.  The parties hereto (i) all agree that any
          action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue,
          which jurisdiction and venue shall be exclusive, and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

      

      

      18.          Notices.  Any notice, consent or request to be given in connection with any of the
          terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile transmission.

      

      

      [Signature Page Follows]

      

      

      
        6

        
          

      

      

      

                                       

      

      

      

      

      

      	 	Sincerely, 

            
	 	 
	 	
              LDH SPONSOR LLC

            
	 	
              By:

            	
              /s/ Christopher Cooper

            
	 	 	
              Name: Christopher Cooper

              Title: Manager

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Marcelo Claure

            
	 	 	
              Name: Marcelo Claure

              Title: Chairman and Director

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Michel Combes

            
	 	 	
              Name: Michel Combes

              Title: President and Director

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Paulo Passoni

            
	 	 	
              Name: Paulo Passoni

              Title: Managing Partner

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Mwashuma Nyatta

            
	 	 	
              Name: Mwashuma (Shu) Nyatta

              Title: Managing Partner

            

      

      

      [Signature Page to Letter Agreement]

      

      
        
          

      

      

      

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Christopher Cooper

            
	 	 	
              Name: Christopher Cooper

              Title: Chief Financial Officer

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Michelle C. Kerrick

            
	 	 	
              Name: Michelle C. Kerrick

              Title: Director

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Annette Franqui

            
	 	 	
              Name: Annette Franqui

              Title: Director

            

      

      

      	 	
              INSIDER

            
	 	
              By:

            	
              /s/ Patricia Wexler

            
	 	 	
              Name: Patricia Wexler

              Title: Director

            

      

      

      

      

      Acknowledged and Agreed:

      

      

      

      

      	 	
              LDH GROWTH CORP I

            
	 	
              By:

            	
              /s/ Michel Combes

            
	 	 	
              Name: Michel Combes

              Title: President

            

      

      

      [Signature Page to Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]